← Back to Analyst Consensus 
MBX Buy
MBX Biosciences, Inc.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Oct 2, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 10, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 29, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| May 12, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 12, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| May 11, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jan 28, 2026 | Barclays | initiate | — → Overweight | $66 | 53% |
| Jan 16, 2026 | Guggenheim | maintain | Buy → Buy | $88 | 52% |
| Jan 7, 2026 | UBS | initiate | — → Buy | $60 | 54% |
| Dec 19, 2025 | Stifel | maintain | Buy → Buy | $50 | 53% |
| Dec 4, 2025 | Goldman Sachs | initiate | — → Sell | $18 | 54% |
| Nov 10, 2025 | Guggenheim | maintain | Buy → Buy | $77 | 52% |
| Nov 4, 2025 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Oct 15, 2025 | Truist Securities | initiate | — → Buy | $50 | 54% |
| Sep 24, 2025 | Mizuho | maintain | Outperform → Outperform | $56 | 52% |
| Sep 23, 2025 | Oppenheimer | maintain | Outperform → Outperform | $80 | 52% |
| Sep 23, 2025 | Guggenheim | maintain | Buy → Buy | $84 | 52% |
| Aug 5, 2025 | Mizuho | initiate | — → Outperform | $38 | 52% |
| Jul 16, 2025 | Oppenheimer | initiate | — → Outperform | $38 | 52% |
| Apr 10, 2025 | JMP Securities | initiate | — → Market Outperform | $38 | 53% |
| Apr 10, 2025 | Guggenheim | reiterate | Buy → Buy | $44 | 52% |
| Oct 8, 2024 | Jefferies | initiate | — → Buy | $35 | 52% |
| Oct 8, 2024 | JP Morgan | initiate | — → Overweight | $30 | 54% |
| Oct 8, 2024 | Stifel | initiate | — → Buy | $40 | 53% |
| Oct 8, 2024 | Guggenheim | initiate | — → Buy | $44 | 52% |
Price Target Trend
Apr 22, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days